Cathie Wood's position in AMGEN is currently worth $16.1 Million. That's 0.15% of their equity portfolio (66th largest holding). Cathie Wood started to build up the position in AMGEN in Q1 2024 and continued to invest until Q3 2024. Since then they sold 17.6 Thousand shares. The investor's estimated purchase price is $17.3 Million, resulting in a loss of 7.4%.
https://www.investing.com/news/company-news/cathie-woods-ark-sells-robinhood-buys-uipath-and-amgen-stock-93CH-3464817
Hello, Reader. If I described a heavily attended, several-day event that celebrated cultural change and new ideas… you might think of the 1969 rock festival ...
When markets closed last month, it became official: Cathie Wood’s ARK Innovation ETF (NYSEARCA: ARKK ) had scored its best-returning month in its 9-year hist...